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Introduction
Renal pelvic dilatation (RPD) is one of the most common
abnormalities detected on antenatal ultrasonography. The
reported incidence is 1-5% of all pregnancies.1-3 RPD may
be unilateral or bilateral, but unilateral RPD is more
common.4-6 It is two times more common among male
foetuses, with the male-to-female (M:F) ratio being 2.5:1.7-9
Different classification systems and cut-offs have been
used for the detection of RPD.10,11 The diagnosis is based
on an increased anteroposterior diameter (APD) of renal
pelvis in transverse plane.12,13 Based on renal pelvic APD it
can be further classified into mild, moderate and
severe.14,15 There is a lack of consensus amongst
obstetricians and sonologists about the follow-up
protocols and post-natal management in these infants.16
One reason could be the uncertain prognosis as RPD may
be a physiological phenomenon or may represent a broad
spectrum of urological conditions. Other factors such as
liquor abnormalities and marked progression in the
follow-up scan help in devising a management plan.
The risk of post-natal pathology is well correlated to the
antenatal RPD in local, regional and international
studies.17-19 A few studies have shown it to be a marker for
aneuploidy as well, however, the likelihood ratio (LR) for
detection of aneuploidies remains low.14,20
The current study was planned to determine the
incidence of antenatal RPD to evaluate antenatal
resolution/progression and post-natal outcome.
Patients and Methods
This retrospective study was conducted at the Aga Khan
University Hospital (AKUH), Karachi, and comprised
ultrasonography and medical records of all pregnant
patients who delivered between January 2011 and
December 2013. Prior approval was obtained from the
institutional ethical review committee. The AKUH, a
private-sector tertiary referral hospital, carries out more
than 5,000 deliveries annually, of which a third are high-
risk pregnancies. It has a well-equipped, 12-bed neonatal
intensive care unit (NICU) and offers maternal and foetal
medicine services. The hospital offers comprehensive
medical record keeping services and expertise in medical
coding using the International Classification of Diseases
(ICD)-09 codes. All investigations and radiological reports
are accessible via an online system. The hospital is moving
towards electronic record keeping.
Routine anomaly scan is offered between 18-23 weeks to
all women enrolled in antenatal care at the unit. For the
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Abstract
Objective: To determine the incidence of antenatal renal pelvic dilatation to evaluate antenatal resolution/
progression and post-natal outcome.
Methods: This retrospective study was conducted at the Aga Khan University Hospital, Karachi, and comprised data
of all women found with renal pelvic dilatation in antenatal scans between January 2011 and December 2013. A cut-
off of 5mm was used to diagnose renal pelvic dilatation. Renal pelvic dilatation was categorised into three groups:
mild (5-6mm in second trimester and 5-9mm in third trimester), moderate (7-10mm in second trimester and 10-15
in third) and severe (more than 10mm in second trimester and more than 15mm in third trimester).
Results: Of the 13,337 scans, renal pelvic dilatation was found in 111(0.8%) cases. The overall mean maternal age
was 28.5 ± 4.2 years. Renal pelvic dilatation was unilateral in 52(46.8%) and bilateral in 59(53.2%) cases. Post-natal
scan was done in 61(55%) cases at the discretion of the neonatologist. A pathological finding was diagnosed in post-
natal scan in 19(17.7 %) cases. Pelvi-ureteric junction obstruction was found in 6(5.4%) neonates, all in the severe
renal pelvic dilatation category.
Conclusion: The incidence of renal pelvic dilatation was low and the outcomes were normal in majority of cases.
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purpose of this study, we screened the antenatal scans of
all patients delivered at the centre for foetal RPD
(minimum renal pelvic diameter of 5mm). Foetuses with
renal pelvic dilatation of less than 5mm and those with
other major abnormalities were excluded. All second and
third trimester scans were performed by experienced
radiologists and foetal medicine consultants using 3.5-5
MHz probe on Toshiba Xario machine (Tokyo, Japan) and
Medison Accuvix V20 (Korea).
Maternal medical records of the patients were further
reviewed for maternal demographic history, newborn
characteristics including gender, weight, Appearance,
Pulse, Grimace, Activity, Respiration (APGAR) scores, post-
natal investigations and management related to foetal
RPD. Medical records of the infants were also reviewed for
follow-up investigations. Post-natal investigations were
performed in the first week of life whenever there was a
clinical indication in the newborn or at the discretion of
the paediatric team. Post-natal ultrasound was performed
on the 3rd day of life. Investigations included ultrasound
kidneys, renal scintigraphy (MAG-3) and micturating
cystourethrogram (MCUG).
RPD was categorised into three groups: mild (5-6mm in
second trimester and 7-9mm in third trimester), moderate
(7-10mm in second trimester and 10-15 in third trimester)
and severe (more than 10mm in second trimester and
more than 15mm in third trimester).10 Antenatal resolution
was defined as a normal renal pelvic diameter of less than
5 mm and progression as an increase of at least 1mm
diameter on subsequent follow-up scan at 32-36 weeks.
The data was recorded in a preformatted questionnaire.
SPSS 19 was used for data analysis. Descriptive analysis
was performed and frequencies and percentages were
calculated for categorical variables. Mean and standard
deviation (SD) was calculated for continuous variables.
Results
Of the 13,337 scans that were screened, RPD was found in
111(0.8%) cases. Of them, 87(78.4%) were boys and
24(21.6%) were girls. The overall mean maternal age was
28.5±4.2 years.
RPD was diagnosed on routine second trimester anomaly
scan in 74(66.7%) cases and was an incidental finding in
the third trimester in 37(33.3%) cases. In the cases
diagnosed in the third trimester, the anomaly scan
showed normal renal pelvic diameter. RPD was unilateral
in 52(46.8%) and bilateral in 59(53.2%) cases. RPD
resolved antenatally on follow-up scan in 85(76.5%) cases.
The diameter increased on follow-up scan in 26(23.5%).
There were 3(2.7%) NICU admissions, all of whom were
due to preterm respiratory distress. In 9(8.1%) of
neonates, antibiotics were administered on the
presumption of sepsis (Table).
There were 70(63%) mild, 26(23.42%) moderate and
15(13.5%) severe RPD cases. Mild RPD resolved in the
antenatal period in 61(87.1%) cases. Post-natal scan was
performed only in 29(41.4%) cases. Vesicouretric reflux
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Figure-1: Outcome of RPD in 111 cases.
RPD: Renal pelvic dilatation. VUR: Vesicoureteric reflux.
HN: Hydronephrosis. PUJO: Pelvi-ureteric junction obstruction.
XRP: Extrarenal pelvis. PUV: Posterior urethral valves.
MCDK: Multicystic dysplastic kidney.
was diagnosed in the post-natal period in 3(4.3%)
neonates in this category.
Outcomes were normal in the moderate RPD category in
23(88.5 %) neonates. Post-natal scans were done in
17(65.3%) cases. None of the infants in this category
underwent any treatment.
In the severe RPD group,
pathological finding was
diagnosed on postnatal scans
in 13(86.7%) patients. Post-
natal scan was done in all
patients in this category.
Renal scintigraphy was
performed in 6(40%) of these
infants; of them, an additional
MCUG was performed in
4(66.67%) infants. Moreover,
2(13.3%) infants required
surgical correction of pelvi-
ureteric junction obstruction
(PUJO) in the post-natal
period, of whom 1(50%) infant
underwent pyeloplasty alone,
while the other underwent
percutaneous nephrostomy
(PCN) placement followed by
pyeloplasty (Figure-1).
Pathologies with PUJO had a
higher maximum dilation of
the renal pelvis (mean
23mm±11 mm, range 13.9-40mm). The ranges in other
pathologies were: extra-renal pelvis (18-28mm),
vesicoureteric reflux (5.2-9mm), multicystic dysplastic
kidney (11.3-24mm). The mean range in the normal
outcome group was 7.0±3.25mm (Figure-2).
Discussion
The incidence of RPD in our obstetric population was 0.8
%. The previous reported prevalence of RPD was in a
range of 1-4.5% of pregnancies.1-3 Some authors have
reported prevalence to be as high as 18% when a lower
cut-off of 3mm for diagnosis was used.21 In some studies,
the prevalence was found to be as high as 2-2.8%.22-25
Chudleigh et al. have reported the incidence to be 0.7% in
a routine low-risk population.20 Ahmad et al. also reported
similar findings.26 Both are comparable to the incidence in
our study population. The wide variation in reported
incidence may be attributed to the difference in cut-offs
used for the diagnosis of RPD and the difference in study
populations.
Studies have reported a higher detection rate of RPD
among male infants.7,9 Although the overall M:F ratio in
our review was 3:1, the ratio was remarkably higher in the
severe RPD group, i.e. 14:1. Kumar et al. in their
retrospective review reported an overall male-to-female
ratio of 1.6:1 and 5:1 in the severe RPD group,
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Figure-2: Box plot showing the antenatal pelvic dilatation in different pathologies. The maximum, minimum and inter-quartile
range in ureteropelvic junction obstruction is higher than in all other pathologies. * and o denote outliers.
Table:Maternal and neonatal characteristics.
Maternal characteristics
Mean Maternal age in years (SD) 28.5 (4.2)
Parity n (%)
Primi 47 (42.3)
Multi 64 (57.7)
Maternal Comorbids n (%)
GDM 16 (14.4)
Others 13 (11.7)
Mean Gestational age at the scan in weeks (SD) 25 (5.7)
Neonatal Characteristics
Mean Birth weight in kg (SD) 3 (0.58)
Gender
Male n (%) 87 (78.4)
Female n (%) 24 (21.6)
Mean apgar score at 1 minute (SD) 7.82 (1.0)
Mean apgar score at 5 minute (SD) 8.85 (0.9)
NICU admission n (%) 3 (2.7)
Antibiotic administration n (%) 9 (8.1)
SD: Standard deviation.
GDM: Gestational diabetes mellitus.
NICU: Neonatal intensive care unit.
demonstrating male predilection in severe RPD.27
In the current study, a cut-off of 5mm for the diagnosis of
RPD was used. Other authors have used similar cut-offs in
their reviews.17,26,28-30 The Foetal Medicine Foundation in
the United Kingdom (UK) also advocates a cut-off of 5mm
while National Health Service (NHS) foetal anomaly
screening programme of the UK defines RPD above or
equal to an APD of 7mm.11,31 There is a general lack of
consensus amongst radiologists, foetal medicine
practitioners and paediatric urologists regarding the
diagnostic criteria of RPD. The Society of Foetal Urology
(SFU) criteria for the diagnosis were only used by 2.9% of
foetal medicine specialists in a survey in 2012.15,16 In 2014,
a multidisciplinary consensus meeting, involving eight
societies with an interest in the diagnosis and
management of RPD, was held in Maryland, United States
to standardise the criteria for diagnosis of RPD.10 Their cut-
offs were comparable to the earlier reported SFU criteria
and defined a cut-off of 4mm at 16-27 weeks. The lower
cut-offs have a high sensitivity for diagnosis of post-natal
pathology. Nevertheless, the specificity is low and using
these cut-offs carries the risk of generating unnecessary
anxiety among the parents.
The outcomes in our review were normal in 95% of cases
in mild RPD, 88% in moderate RPD and 13% in severe RPD.
Antenatal resolution was seen in 76.6% of cases. Other
authors have reported a similar resolution rate.25,26,28 A
multivariable retrospective review by Longpre et al. in
201232 reported similar results with a high rate of
pathology in initial severe RPD. They also reported that an
APD of less than 1.93cm has a positive predictive value of
88% for resolution. A meta-analysis by Lee et al. showed
an 88.3% risk of pathology with severe RPD which is
consistent with our results (86.6%).18
The mean RPD in babies with PUJO in our review was
(23mm range 13.9mm-40mm). These results are
consistent with an earlier review by Coplen et al.33
In our review only two infants underwent surgery (1.8%),
which is much lower than what earlier reviews have
defined, some as high as 25-40%.4,14,32 The difference in
rates is likely due to the varied range of follow-up in
different studies. Since this was a retrospective review, all
the information regarding follow-up was taken from the
medical records and some of the infants may have had
surgery in another facility.
The identified limitations in our review were a
retrospective design, short-term follow-up and post-natal
investigations not being carried out in all neonates. These
were mainly due to limited financial resources of the
parents restricting prolonged follow-ups. Nevertheless,
the study highlights the importance of identifying and
reporting RPD in the antenatal scans and the need for a
follow-up scan in third trimester and post-natal period.
Mild RPD with resolution in the third trimester scan is
more likely to be a normal variant. Using a 5mm cut-off in
the second trimester with a follow-up scan in the third
trimester is the most valid approach at present. Post-natal
evaluation is recommended if RPD persists or shows
progression. These results will help in counselling the
prospective parents regarding RPD.
Conclusion
The incidence of RPD was found to be very low and
outcomes were normal in 95% of cases.
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